Published in Health Business Week, May 2nd, 2008
The media has recently focused on escalating specialty drug costs of rare, serious or chronic diseases such as cancer, rheumatoid arthritis or psoriasis as a significant driver of higher health care costs. However, overlooked are the costs of administering those drugs via injections, vaccines and infusions. Patient payments for these services can be thousands of dollars per visit. Furthermore, physicians have been exiting the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.